Pharmaceutical

AbbVie and Richter partner for neuropsychiatric treatments

AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.

Oct 26, 2024 - 04:00
AbbVie and Richter partner for neuropsychiatric treatments
AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.
Read the original article

Tags:

Previous Article

Takeda and BMC partner to decarbonise US healthcare sector

Next Article

US CDC AdCom recommends lowering the age for pneumococcal vaccines

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

RespireRx and UCL partner to study AMPAkines for GRIA Disorder

RespireRx and UCL partner to study AMPAkines for GRIA D...

Apr 6, 2023

IGM jettisons workforce and blood cancer programme to refocus pipeline

IGM jettisons workforce and blood cancer programme to r...

Dec 6, 2023

Daiichi Sankyo receives Japan’s MHLW approval for VANFLYTA

Daiichi Sankyo receives Japan’s MHLW approval for VANFLYTA

May 26, 2023